Laboratory of Microbiology, Virgen de Las Nieves University Hospital & Biosanitary Research Institute of Granada (Ibs.GRANADA), 18016, Granada, Spain.
Department of Microbiology, School of Medicine, University of Granada & Biosanitary Research Institute of Granada (Ibs.GRANADA), 18016, Granada, Spain.
Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):517-524. doi: 10.1007/s10096-024-04747-5. Epub 2024 Jan 12.
We evaluated a modification of automated antibiograms in urine cultures designed to facilitate the early interpretation of minimum inhibitory concentrations (MICs) and accelerate the targeted treatment of urinary tract infections (UTIs), METHODS: A prospective study was conducted of 309 isolates (219 Enterobacteriaceae, 75 Enterococcus spp., and 15 non-fermenting Gram-negative bacilli (NFGNB), and a retrospective study of 9 carbapenemase-producing clinical isolates from urine cultures. Colonies grown on conventional isolation plates were inoculated in MicroScan Walkaway system panels and incubated for 7 h, using a MicroScan AutoScan-4 plate reader for preliminary MIC determination by turbidimetry. Resulting antibiograms were compared with definitive antibiograms obtained after incubation for 17 h.
Preliminary and definitive readings were concordant for 86.7% of Gram-positive cocci isolates (65/75), 61.6% of Enterobacteriaceae (135/219), and 53.3% of NFGNB. The agreement rate was greater than 90% for most antimicrobials against Gram-positive cocci (94.7% or more) and Enterobacteriaceae, (97.2% or more for 10 of 17 antibiotics) except with nitrofurantoin (89%). The agreement rate was 86.7% or more for most antibiotics against NFGNB apart from piperacillin/tazobactam, aztreonam, amikacin, and ciprofloxacin. Gram-negative bacilli showed the highest differences in MIC values between preliminary and definitive readings.
A preliminary antibiogram reading may be useful in urine cultures to reduce the delay before targeted antibiotherapy, especially against Enterobacteriaceae and Gram-positive cocci, but not in cases of carbapenemase-producing NFGNB. Further local studies are warranted to evaluate the usefulness of this approach in relation to resistance rates.
我们评估了一种尿液培养物自动化药敏试验的改良方法,旨在促进最小抑菌浓度(MIC)的早期解读,并加速尿路感染(UTI)的靶向治疗。方法:前瞻性研究了 309 株分离株(219 株肠杆菌科、75 株肠球菌属和 15 株非发酵革兰氏阴性杆菌(NFGNB)),并回顾性研究了 9 株来自尿液培养物的产碳青霉烯酶临床分离株。在常规分离平板上生长的菌落接种到 MicroScan Walkaway 系统板中,并孵育 7 小时,使用 MicroScan AutoScan-4 平板读数仪通过比浊法进行初步 MIC 测定。将所得药敏试验结果与孵育 17 小时后获得的确定药敏试验结果进行比较。结果:初步和确定的读数在 86.7%的革兰氏阳性球菌分离株(65/75)、61.6%的肠杆菌科(135/219)和 53.3%的 NFGNB 中一致。对于大多数针对革兰氏阳性球菌(94.7%或更高)和肠杆菌科的抗菌药物,一致性率大于 90%(17 种抗生素中有 10 种的一致性率为 97.2%或更高),除了呋喃妥因(89%)。对于大多数针对 NFGNB 的抗生素,除了哌拉西林/他唑巴坦、氨曲南、阿米卡星和环丙沙星外,一致性率为 86.7%或更高。革兰氏阴性杆菌的 MIC 值在初步和确定的读数之间差异最大。结论:在尿液培养物中进行初步药敏试验可以减少靶向抗生素治疗的延迟,特别是针对肠杆菌科和革兰氏阳性球菌,但对于产碳青霉烯酶的 NFGNB 则不然。需要进一步的本地研究来评估这种方法在耐药率方面的实用性。